Academic Medical Centre / Academisch Medisch Centrum (AMC)

Pediatric kidney transplantation in Europe, a clinical snapshot pilot () Oomen L, Bootsma-Robroeks CM, Bouts AH, Carbonell Pradas M, Gander R, Kienzl-Wagner K, König P, et al. Journal article Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy (2024) Bergner CG, Breur M, Soto-Bernardini MC, Schäfer L, Lier J, Le Duc D, Bundalian L, et al. Journal article Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation - A Retrospective Multicenter Outcome Analysis (2024) Assfalg V, Miller G, Stocker F, Hüser N, Hartmann D, Heemann U, Tieken I, et al. Journal article Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. (2024) Brivio E, Pennesi E, Willemse ME, Huitema AD, Jiang Y, Van Tinteren HD, Van Der Velden VH, et al. Journal article Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme (2022) Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, et al. Journal article Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries (2022) Skoric-Milosavljevic D, Tadros R, Bosada FM, Tessadori F, Van Weerd JH, Woudstra O, Tjong FVY, et al. Journal article Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies (2021) Espinosa-Ortega F, Holmqvist M, Lodin K, Dastmalchi M, Danieli MG, Venkovsky J, Knitza J, et al. Conference contribution Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. (2020) Male C, Lensing AW, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, et al. Journal article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial (2019) Van Geuns RJ, Smits PC, Chang CC, Wlodarczyk A, Chevalier B, West N, Gori T, et al. Conference contribution